David Meininger

SovranBio

BIOGRAPHY

David Meininger is the Founder of SovranBio, a company dedicated to developing multispecific biologics through novel scaffolds and target combinations, including an ADC collaboration focused on rapidly advancing the company's pipeline. He previously served as the CEO at Link Immunotherapeutics, guiding the company's lead program from conception through an approved IND.

David brings extensive biopharmaceutical leadership experience, including his tenure as the Executive Director at Merck, where he contributed to the development of Keytruda.